This content is machine translated Annual Meeting of the Swiss Brain Stroke Society, Zurich PCSK9 inhibitors keep acute coronary syndrome at bay It is well known that low LDL cholesterol reduces the risk of cardiovascular disease. But in practice, this is often easier said than done. Are PCSK9 inhibitors the solution?
View Post 13 min This content is machine translated Type 2 diabetes Focus on heart & kidney: therapy choice in patients with limiting factors Classes of drugs with different mechanisms of action are available for the treatment of type 2 diabetes. However, the presence of renal or cardiac insufficiency, cardiovascular disease, or insulin deficiency…
View Post 8 min This content is machine translated Accidental hypothermia “Nobody is dead until warm and dead” Although hypothermia is a rather rare phenomenon, mortality is still relatively high today. Rapid recognition of hypothermia and adequate treatment make the difference between life and death.
View Post 8 min This content is machine translated Therapy refractory heart failure Mechanical circuit support in theory and practice Patients with refractory cardiovascular failure are dependent on mechanical circulatory support. When do short-term systems such as ECMO or Impella come into play? In which cases is long-term support provided?
View Post 10 min This content is machine translated Carotid stenosis Overview of current treatment options Today, the treatment of carotid stenosis is interdisciplinary and individualized. Findings from earlier studies cannot be readily applied to today’s situation because medical advances have changed the boundary conditions. What…
View Post 4 min This content is machine translated AHA Scientific Sessions 2018 Dapagliflozin reduces heart failure hospitalization rate Diabetes is associated with an increased cardiovascular risk, which should be taken into account therapeutically. In 2015, the EMPA-REG OUTCOME study demonstrated positive cardiovascular effects of the SGLT-2 inhibitor empagliflozin.…
View Post 9 min This content is machine translated vvECMO and vaECLS Bridge-to-decision in respiratory failure and cardiogenic shock. Studies such as CESAR or SHOCK II, but also the further development of pumps, oxygenators and perfusion tubing have contributed to the fact that therapy with ECMO and ECLS has…
View Post 7 min This content is machine translated Peripheral arterial occlusive disease Rare causes and differential diagnoses The clinic of degenerative changes is difficult to distinguish from that of peripheral arterial disease (PAVD), and measurement of ABI is indicative.
View Post 7 min This content is machine translated Marfan syndrome and related connective tissue diseases How is long-term cardiovascular care provided to patients? Surgical treatment of patients with hereditary connective tissue disease aims to prevent aortic dissection. This is because it is responsible for the high mortality rate of the patient population. When…
View Post 8 min This content is machine translated Operation in focus When and how is surgical therapy for PAVK performed? The surgical techniques used to rehabilitate peripheral arterial disease (PAVD) are thromboendarterectomy and bypass grafting. Which procedure is used when, how does the operation proceed and what should be taken…
View Post 7 min This content is machine translated Chronic heart failure MitraClips: What do studies say? The use of percutaneous mitral valve repair using a MitraClip device for the treatment of (moderately) severe functional mitral regurgitation is controversial. Previous studies were either terminated due to insufficient…
